Enhanced Medical Nutrition over-subscribes pre-series A financing, announces strategic investment from dsm-firmenich

OBIO NewsOntario Industry Updates
Written By Arsheen Kaur

Enhanced Medical Nutrition, Inc. (EMN) recently announced the successful closing of an over-subscribed Pre-Series A equity financing supported by dsm-firmenich venturing, The Kale Fund, Keiretsu Forum, and various angel investors. The financing comes on the heels of EMN's expansion across more than 150 orthopaedic providers. Proceeds of the transaction will be used to fund EMN's operations and growth.

EMN is an OBIO® member, an alumnus of all our programs and presented at the OBIO® Investment Summit.

Arsheen Kaur
Previous

Northern Nanopore Instruments acquired by Oxford Nanopore Technologies
Next

Edesa Biotech to receive up to CAD $23 Million in funding from Federal Government